It’s interesting to note that patients with T1DM and T2DM had higher serum levels of sclerostin (83, 84), indicating variations in glucose concentration may have impact on the cells most crucial for maintaining bone health as sclerostin is largely produced by osteocytes. This evidence concerns the gene SOST and type 2 diabetes mellitus.